The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells.

Détails

Ressource 1Télécharger: BIB_E427ADEC633E.P001.pdf (5862.87 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_E427ADEC633E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells.
Périodique
Nature Communications
Auteur⸱e⸱s
Woldt E., Terrand J., Mlih M., Matz R.L., Bruban V., Coudane F., Foppolo S., El Asmar Z., Chollet M.E., Ninio E., Bednarczyk A., Thiersé D., Schaeffer C., Van Dorsselaer A., Boudier C., Wahli W., Chambon P., Metzger D., Herz J., Boucher P.
ISSN
2041-1723 (Electronic)
ISSN-L
2041-1723
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
3
Numéro
1077
Pages
1-10
Langue
anglais
Notes
Publication types: Journal Article
Résumé
Vascular calcification is a hallmark of advanced atherosclerosis. Here we show that deletion of the nuclear receptor PPARγ in vascular smooth muscle cells of low density lipoprotein receptor (LDLr)-deficient mice fed an atherogenic diet high in cholesterol, accelerates vascular calcification with chondrogenic metaplasia within the lesions. Vascular calcification in the absence of PPARγ requires expression of the transmembrane receptor LDLr-related protein-1 in vascular smooth muscle cells. LDLr-related protein-1 promotes a previously unknown Wnt5a-dependent prochondrogenic pathway. We show that PPARγ protects against vascular calcification by inducing the expression of secreted frizzled-related protein-2, which functions as a Wnt5a antagonist. Targeting this signalling pathway may have clinical implications in the context of common complications of atherosclerosis, including coronary artery calcification and valvular sclerosis.
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/11/2012 19:43
Dernière modification de la notice
20/08/2019 17:07
Données d'usage